Genzyme

Genzyme

Genzyme (pronounced: jen-zyme) is a pioneering biotechnology company that has been a part of Sanofi, a global healthcare leader, since 2011.

Etymology

The name "Genzyme" is a portmanteau of the words "genetic" and "enzyme", reflecting the company's focus on genetic diseases and enzyme replacement therapies.

History

Genzyme was founded in 1981 in Boston, Massachusetts, USA. The company was initially focused on developing treatments for patients with rare genetic diseases. In 2011, Genzyme was acquired by Sanofi, a multinational pharmaceutical company, and became its global center for excellence in rare diseases and multiple sclerosis.

Products and Services

Genzyme has developed and brought to market several innovative treatments for patients with rare genetic diseases, such as Gaucher's disease, Fabry disease, Pompe disease, and Mucopolysaccharidosis I (MPS I). The company also provides treatments for thyroid cancer, multiple sclerosis, and cholesterol management.

Related Terms

• Biotechnology
• Sanofi
• Gaucher's disease
• Fabry disease
• Pompe disease
• Mucopolysaccharidosis I (MPS I)
• Thyroid cancer
• Multiple sclerosis
• Cholesterol management

External links

• Medical encyclopedia article on Genzyme
• Wikipedia's article - Genzyme

This WikiMD dictionary article is a stub. You can help make it a full article.

---

Languages: - East Asian 中文, 日本, 한국어, South Asian हिन्दी, Urdu, বাংলা, తెలుగు, தமிழ், ಕನ್ನಡ,
Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, European español, Deutsch, français, русский, português do Brasil, Italian, polski